White Pine Investment CO Q4 2022 vs. Q1 2023 13F Holdings Comparison

As investors, we always want to know what top-performing fund managers are buying and selling in their portfolios. The recent 13F disclosures by White Pine Investment CO have revealed some interesting changes in their holdings from Q4 2022 to Q1 2023. In this article, we will discuss the significant changes and the possible reasons behind them.

Goldman Sachs ActiveBeta Inter (GSIE) - Up by 12.2%

White Pine Investment CO has increased its holdings in Goldman Sachs ActiveBeta Inter (GSIE) by over 17,000 shares from Q4 2022 to Q1 2023. The value of their investment has also increased by $1.25 million, which represents a 12.2% increase. Goldman Sachs ActiveBeta Inter is an ETF that offers exposure to US equities across multiple sectors.

Alphabet Inc (GOOGL) - Up by 19.8%

White Pine Investment CO also added to its holdings in Alphabet Inc (GOOGL) during this period. They bought over 1,900 additional shares, increasing their investment value by over $800,000. This represents a 19.8% increase in their investment. Alphabet Inc is a well-established tech company that operates under the Google brand.

Xtrackers MSCI EAFE High Div Yld Eq ETF (HDEF) - Up by 335.1%

White Pine Investment CO made a significant increase in its holdings in Xtrackers MSCI EAFE High Div Yld Eq ETF (HDEF) from Q4 2022 to Q1 2023. The firm added over 348,000 shares of the ETF, representing a whopping 335.1% increase in investment. The investment in HDEF is focused on overseas securities, which could be a bet on the international rebound from the COVID-19 pandemic.

CVS Health Corp (CVS) - Down by 18.3%

One of the notable sales by White Pine Investment CO was of their holdings in CVS Health Corp (CVS). The firm sold over 2,100 shares, reducing their investment value in the company by over $1.4 million. This represents an 18.3% reduction in their investment. One of the possible reasons behind this move could be the company's declining revenue growth in recent quarters.

Pfizer Inc (PFE) - Down by 33.1%

White Pine Investment CO also reduced its holdings in Pfizer Inc (PFE) from Q4 2022 to Q1 2023. They sold over 8,700 shares, representing a 33.1% decrease in their investment. Pfizer Inc is a well-known pharmaceutical company that has been in the news extensively due to its COVID-19 vaccine distribution.

Conclusion

In conclusion, White Pine Investment CO made some interesting moves in their portfolio from Q4 2022 to Q1 2023. The decision to increase their holdings in GSIE, GOOGL, and HDEF may indicate that the firm believes in the long-term prospects of these companies. On the other hand, the decision to reduce their holdings in CVS and PFE may indicate that the firm sees risks associated with these investments. However, it's important to note that the reasons behind these moves can only be speculated upon, as 13F disclosures only provide a snapshot of a fund manager's holdings at a particular point in time.